These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8973459)

  • 1. Down's syndrome screening with nuchal translucency.
    Hackshaw AK; Wald NJ; Haddow JE
    Lancet; 1996 Dec 21-28; 348(9043):1740. PubMed ID: 8973459
    [No Abstract]   [Full Text] [Related]  

  • 2. First trimester nuchal translucency: effective routine screening for Down's syndrome.
    Thilaganathan B; Sairam S; Michailidis G; Wathen NC
    Br J Radiol; 1999 Oct; 72(862):946-8. PubMed ID: 10673944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine lethality of trisomy 21 fetuses with increased nuchal translucency thickness.
    Hyett JA; Sebire NJ; Snijders RJ; Nicolaides KH
    Ultrasound Obstet Gynecol; 1996 Feb; 7(2):101-3. PubMed ID: 8776233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining ultrasound and biochemistry in first-trimester screening for Down's syndrome.
    Wald NJ; Hackshaw AK
    Prenat Diagn; 1997 Sep; 17(9):821-9. PubMed ID: 9316126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome.
    Kadir RA; Economides DL
    Ultrasound Obstet Gynecol; 1997 Apr; 9(4):244-7. PubMed ID: 9168574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness.
    Pandya PP; Snijders RJ; Johnson S; Nicolaides KH
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):381-3. PubMed ID: 7552798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First trimester Down Syndrome screening by nuchal translucency in a Thai population.
    Panburana P; Ajjimakorn S; Tungkajiwangoon P
    Int J Gynaecol Obstet; 2001 Dec; 75(3):311-2. PubMed ID: 11728495
    [No Abstract]   [Full Text] [Related]  

  • 9. Down's syndrome screening with nuchal translucency.
    Nicolaides KH; Sebire NJ; Snijders RJ
    Lancet; 1997 Feb; 349(9049):438. PubMed ID: 9033507
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population.
    Pajkrt E; van Lith JM; Mol BW; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):163-9. PubMed ID: 9793187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester screening for fetal aneuploidy: biochemistry and nuchal translucency.
    Orlandi F; Damiani G; Hallahan TW; Krantz DA; Macri JN
    Ultrasound Obstet Gynecol; 1997 Dec; 10(6):381-6. PubMed ID: 9476320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does gender have an impact on the sonographic detection of second-trimester fetuses with Down's syndrome?
    Benacerraf BR; Miller WA; Nadel A; Pauker S; Bromley B
    Ultrasound Obstet Gynecol; 1995 Jan; 5(1):30-3. PubMed ID: 7850586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ethnic origin on nuchal translucency screening for Down's syndrome.
    Thilaganathan B; Khare M; Williams B; Wathen NC
    Ultrasound Obstet Gynecol; 1998 Aug; 12(2):112-4. PubMed ID: 9744055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculating correct Down's syndrome risks.
    Cuckle H; Sehmi I
    Br J Obstet Gynaecol; 1999 Apr; 106(4):371-2. PubMed ID: 10426246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased first trimester nuchal translucency: pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population.
    Adekunle O; Gopee A; el-Sayed M; Thilaganathan B
    Br J Radiol; 1999 May; 72(857):457-60. PubMed ID: 10505009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [First trimester ultrasound screening for nuchal translucency as marker of Down's syndrome].
    Herman A; Maymon R; Dreazen E; Bukovsky I; Weinraub Z
    Harefuah; 1997 Jan; 132(2):94-100. PubMed ID: 9119309
    [No Abstract]   [Full Text] [Related]  

  • 18. Prenatal ultrasound evaluation now possible in first trimester. Nuchal translucency thickness can spot Down's syndrome.
    Krotz D
    Diagn Imaging (San Franc); 1998 Sep; 20(9):13, 15. PubMed ID: 10187447
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fetal nuchal edema in the 11th to 14th week of pregnancy--an indication of trisomy?].
    Kuhn P
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2494-8. PubMed ID: 8571100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Down's syndrome by fetal nuchal translucency measurement in a high-risk population.
    Pajkrt E; Mol BW; van Lith JM; Bleker OP; Bilardo CM
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):156-62. PubMed ID: 9793186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.